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Previous work has demonstrated that phorbol ester (TPA)-induced adherence of human U937 myeloid
leukemia cells can be blocked upon down-modulation of the β2-integrin CD11b after stable transfection
of U937 cells with a pMTH1 vector-containing the CD11b gene in antisense orientation (asCD11b-U937)
[Otte et al., (2011)]. In the present study, alterations in metabolism-associated factors, particularly intra- and
extracellular proteases were investigated. A measurement of telomerase activity in the leukemic cells
revealed continuously decreasing telomere adducts within 72 h of TPA treatment in pMTH1-U937 cells. In
contrast, telomerase activity sustained in asCD11b-U937 upon TPA-induced differentiation. Flow cytometric
analysis confirmed unchanged CD11b levels in TPA-induced asCD11b-U937 in contrast to elevated levels
in pMTH1-U937 whereby the expression of other β2-integrins including CD11a, CD11c and CD18 was
increased in both populations after TPA treatment. Moreover, adherent pMTH1-U937 demonstrated the
expression of monocytic differentiation markers including F4-80 and CD14 and an increased MIP-1α
production which remained at low or undetectable in TPA-induced asCD11b-U937. These effects indicated
an altered response of the different cell populations to the TPA-induced differentiation process. Indeed,
Western blot analysis revealed differences in the expression levels of intracellular metabolic factors including MnSOD
and p97/VCP and after measurement of 20 S proteasomal proteolytic activity. In addition, increased levels of
extracellular metabolic factors including the matrix metalloproteinases MMP-1, MMP-7 and MMP-9 were observed in
pMTH1-U937 cells in contrast to unaltered levels in asCD11b-U937 cells.
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The human U937 myeloid leukemia cell line represents an
in vitro model for monocyte/macrophage-like differenti-
ation and retrodifferentiation [1-5]. A variety of molecular
effects by differentiation-inducing agents such as the phor-
bol ester derivate 12-O-tetradecanoyl-phorbol-13-acetate
(TPA) on cell adherence and filament expression in U937
cells have been extensively characterized [6,7]. Thus, the
non-adherent growing and like tumor cells autonomously
proliferating U937 wild-type population can be stimulated
by TPA to differentiate along the monocyte/macrophage* Correspondence: hass.ralf@mh-hannover.de
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reproduction in any medium, provided the orpathway which is associated with induced adherence and
cessation of cell growth. The TPA-mediated attachment of
differentiating U937 cells is accompanied by an enhanced
expression of the β2-integrins CD11a, CD11c, CD18,
and particularly CD11b [6]. These integrin compounds are
cell membrane-associated glycoproteins whereby CD11a,
CD11b and CD11c represent separate α-subunits to associ-
ate with the common β-subunit CD18, respectively. The
appropriate heterodimeric protein complex forms a func-
tional β2-integrin which is involved in the formation of
cell-to-cell contacts and intercellular communication
processes [8]. Moreover, junctional adhesion molecules
including ICAMs can associate through their extracellular
domains with functional β2-integrins on adjacent cells,
contributing for example to the regulation of leukocyte-
endothelial cell interactions [9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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defective subclone of the U937 cell line, termed TUR
(TPA-U937-resistant), fails to express significant levels of
CD11b after TPA treatment [10]. Concomitantly, these
human TUR leukemia cells are unable to attach and
continue to proliferate in response to a phorbol ester stimu-
lation [11] indicating that CD11b displays a differentiation-
associated function beyond an involvement in the
regulation of cell attachment. Indeed, previous work
has demonstrated that a down-modulation of the CD11b
integrin fails to develop certain markers of a monocytic
phenotype following exposure to the differentiation-
inducing TPA [1,12]. Such a differentiation program along
the monocyte/macrophage-like lineage in TPA-treated
U937 cells requires significant metabolic changes and other
studies have shown that this process is accompanied by
alterations in the expression and activity of metabolizing
factors including the 20 S proteasome [13], manganese per-
oxidase [14] and the valosin-containing protein VCP/p97
[7]. Moreover, the acquired adherence of myelocytic cells
during monocytic maturation is paralleld by a restructure
of the extracellular matrix involving a variety of matrix
metalloproteinases such as MMP-1, MMP-7 and MMP-9
[14].
Whereas previous work has determined the role of
CD11b integrin-mediated cell attachment and cell cycle
progression within a monocytic differentiation program
[1], little is known about intracellular and extracellular
metabolic enzymes which may affect restructure of the
extracellular matrix and are also relevant for maturation
along the monocytic lineage.
It was therefore of interest in the present study, to
examine the role of down-modulated CD11b integrin on
metabolic factors represented by the expression levels
and activation of distinct intracellular and extracellular
protease systems after phorbol ester treatment.Material and methods
Cell culture
Human U937 myeloid leukemia cells (American Type
Culture Collection #CRL-1593.2) were cultured in RPMI
1640 containing 10% of heat-inactivated fetal bovine
serum, 100 units/ml penicillin, 100 μg/ml streptomycin,
and 2 mM L-glutamine in a 37°C humidified atmosphere
with 5% CO2. Moreover, U937 cells stably transfected with
the pMTH1 vector (pMTH1-U937) and U937 cells stably
transfected with the pMTH1 vector containing the CD11b
gene in antisense orientation (asCD11b-U937) [12] were
cultured under similar conditions. The different cell popu-
lations were incubated with 5nM of the differentiation-
inducing agent 12-O-tetradecanoylphorbol-13-acetate
(TPA) (Sigma Chemie GmbH, Taufkirchen, Germany)
for different time points as indicated.Telomerase assay
Using a radioactive assay the activity of this nuclear enzyme
in U937 cells, pMTH1-U937 and asCD11b-U937 cells was
detected by TRAPeze telomerase detection kit (Millipore,
Beverly, MA, USA). Briefly, homogenates of pMTH1-U937
and asCD11b-U937 cells after TPA exposure at distinct
time points was resuspended in CHAPS lysis buffer and
combined with a reaction mixture including a [γ-32P]
ATP radiolabeled TS primer previously labelled by T4-
polynucleotide kinase (NEB, Beverly, MA, USA). Evalu-
ation and adjustment of equal protein was performed using
the Bradford method (Bio-Rad Inc., Richmond, CA, USA).
The different pMTH1-U937 and asCD11b-U937 protein
samples were subjected to PCR amplification using Taq
DNA polymerase (NEB, Beverly, MA, USA) according to
the manufacturer’s instructions. Following the addition of
loading dye the amplified DNA samples were separated in
a 10% non-denaturing polyacrylamide gel. Thereafter, the
gel was dried and the radiolabelled telomere bands were
visualized in a PhosphoImager (Storm 820, Amersham
Biosciences).Flow cytometry analysis
Steady state cultures of pMTH1-U937 control cells and
asCD11b-U937 were harvested, washed in phosphate-
buffered saline/bovine serum albumin (PBS-BSA), and
plated at 1x106 cells/well in round-bottom microtiter
plates (BD Biosciences GmbH, Heidelberg, Germany).
Fc-receptors were blocked by addition of 20 μl of human
IgG, diluted to 10 mg/ml for 30 min at 4°C. The cells were
washed with PBS-BSA and aliquots were incubated with a
1:50 dilution of the fluorescein isothiocyanate (FITC)-
conjugated monoclonal antibodies anti-human CD11a
(Serotec Ltd., Oxford, U.K.) and anti-human CD18 (Sero-
tec) for 1 h/4°C in the dark. Furthermore, aliquots of the
cells were also incubated with a 1:50 dilution of a RPE-
labeled monoclonal anti-human CD11b (Biozol GmbH,
Eching, Germany), anti-human CD11c (Serotec), anti-
human CD14 (Serotec), and the rat anti-mouse F4-80 anti-
body (Boehringer Mannheim) for 1 h/4°C, respectively.
After three washes with PBS/BSA the cells containing the
non-labelled antibodies were incubated with a secondary
FITC-conjugated rabbit anti-mouse (Dianova GmbH,
Hamburg, Germany), and in case of the F4-80 with a
FITC-conjugated sheep anti-rat (Dianova) antibody for 1 h/
4°C, respectively. Following antibody incubation all samples
were washed twice with PBS-BSA and flow cytometry was
performed in a Galaxy FACSan (Partec) using FloMax ana-
lysis software (Partec).Measurement of the nuclear proteasomal proteolytic activity
About 5 × 105 U937 cells, pMTH1-U937 control cells
and asCD11b-U937 cells were exposed to 5nM TPA for
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points indicated the different cell populations were har-
vested and enrichment of nuclei was performed as
described previously [7] to minimize contamination of
other cellular components. The isolated nuclei were
lysed by 5 freeze-thawing-cycles in 10 mM HEPES (pH
7.5), 24 mM KCl, 10 mM MgCl2 and 0.5 mM DTT. The
proteasome activity in nuclear lysates was measured as
described previously [15]. Briefly, the peptidase activity
toward the hydrophobic fluorogenic peptide succinyl-
leucine-leucine-valine-tyrosine-methylcoumaryl-amide
(suc-LLVY-MCA) was measured by incubation with
50 mM Tris–HCl (pH 7.8), 20 mM KCl, 5 mM MgOAc,
0.5 mM DTT and 200 μM suc-LLVY-MCA for 1 h at
37°C in the presence and absence of 10 μM lactacystin.
After incubation for 2 h at 37°C, the reaction was
stopped by the addition of an equal volume of ice-cold
ethanol and a 10-fold volume of 125 mM sodium borate
(pH 9.0). Thereafter, fluorescence intensity was deter-
mined at 380 nm excitation and 440 nm emission
wavelength.
Measurement of Mip-1α production
About 5×105 U937 cells, pMTH1-U937 control cells and
asCD11b-U937 cells were exposure to 5nM TPA for 4 h,
8 h, 24 h, 48 h and 72 h, respectively. Following incubation,
100 μl aliquots of the appropriate supernatant were trans-
ferred into an anti-Mip-1α-precoated microtiter plate and
analysed for Mip-1α by enzyme-linked immunosorbent
assay (ELISA) according to the manufacturer’s instructions
(Tebu-Bio, Offenbach, Germany). After the stop solution
was applied to each sample, absorption at 450 nm was im-
mediately measured in a Multiskan EX ELISA reader
(ThermoFischer Scientific, Langenselbold, Germany).
Immunoblot analysis
The immunoblot analysis was performed in accordance
to a closely-related recent study [1]. Thus, untreated and
5nM TPA-stimulated pMTH1-U937 and asCD11b-U937
cells were washed three times in ice-cold PBS and lysed
in a buffer containing 10 mM Tris–HCl (pH 7.6),
140 mM NaCl, 10 mM EDTA, 1% (v/v) NP-40 with the
addition of 10 μg/ml aprotinin, 10 μg/ml leupeptin, and
1 mM phenylmethylsulfonylfluoride (PMSF) (all from
Sigma). Protein concentration was adjusted using the
colorimetric BCA-assay (Perbio Science Deutschland,
Bonn, Germany), subjected to SDS-polyacrylamide gel
electrophoresis and transferred to a PVDF membrane
(Millipore GmbH, Schwalbach, Germany). The mem-
branes were blocked with PBS containing 5% FCS and
0.05% Tween-20 (PBS/Tween). After washing four times
with PBS/Tween, the membranes were incubated with
the primary antibodies and subsequently stripped. Fol-
lowing primary antibody incubation (polyclonal anti-MnSOD (Upstate Inc., Lake Placid, NY, USA); polyclonal
anti-p97/VCP (Novus Biologicals Inc., Littleton, CO,
USA); monoclonal anti-proteasome, clone MCP231
(Enzo Life SciencesGmbH, Lörrach, Germany); poly-
clonal anti-MMP-1 (Biomol); monoclonal anti-MMP-7,
clone 111433 (Biomol); polyclonal anti-MMP-9 (Biomol)
and monoclonal anti-β-actin, clone AC-15 (Sigma) for
2 h/37°C, the membranes were washed four times with
PBS/Tween and incubated with the appropriate horserad-
dish peroxidase-conjugated secondary antibody (all from
Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h/37°C.
The membranes were washed with PBS/Tween and visua-
lized by autoradiography using the ECL-detection kit (GE
Healthcare, München, Germany).
Gelatin zymography for detection of MMP gelatinase
activity
Following exposure of 107 U937 cells, pMTH1-U937 cells
and asCD11b-U937 cells to 5nM TPA for 72 h, respect-
ively, the cells were washed in PBS and incubated in 20 ml
RPMI-1640 medium containing only 0.1% FCS for 24 h.
Similarly, non-induced controls were seeded in the same
media and cell density for 24 h. Thereafter, the conditioned
media supernatants were collected and concentrated
18-fold using Amicon Ultra-4 Centrifugal Filter Devices
(Millipore, Carrigtwohill, Ireland) according to the manu-
facturer’s instructions. These concentrated media samples
were used in a zymographic assay to detect any gelatinase
proteolytic activity corresponding to certain MMPs. Thus,
25 μl aliquotes of the samples were mixed 2:1 (v/v) with
non-reducing sample buffer (10 mM Tris (pH 68), 1%
SDS, 10% glycerol and 0.02% bromophenol blue) and sub-
jected to SDS-PAGE containing 2 mg/ml of gelatine
(Sigma, Steinheim, Germany). Electrophoresis was per-
formed for 30 min at 60 V followed by 120 min at 125 V.
The gels were washed twice in 2.5% Triton X-100 on a ver-
tical shaker and five times with H2O. Thereafter, the gels
were incubated with fresh MMP enzyme buffer (50 mM
Tris–HCl, pH 7, 5 mM CaCl2) overnight at 37°C. Finally,
the gels were stained with 0.4% Coomassie blue (methanol/
acetic acid/H2O (40:10:50)) for 1 h and destained with 10%
acetic acid in 50% methanol until bands were visualized.
The proteolytic activity was detected by the appearance of
light bands against the dark blue background.
Results
The tumor cell properties of wild-type U937 control
cells, pMTH1-U937 and asCD11b-U937 human myeloid
leukemia cells was measured by the telomerase activity
assay and after induction of differentiation with 5nM
TPA (Figure 1a). Thus, pMTH1-U937 cells demon-
strated a detectable constitutive telomerase activity
whereby TPA treatment abolished this telomerase activ-
ity after 72 h (Figure 1a). In contrast, asCD11b-U937
Figure 1 a: Telomerase activity. Telomerase activity was detected by TRAPeze telomerase detection kit (Millipore, Beverly, MA, USA). Thus,
radiolabeled telomere adducts were measured in the wild-type U937 control cells as compared to pMTH1-U937 and asCD11b-U937 cells
following culture in the absence and in the presence of 5nM TPA for 24 h up to 72 h, respectively. One representative telomerase assay out of
three similar ones is presented. b: Proliferation assay. About 2 × 104 cells (either U937, pMTH1-U937 or asCD11b-U937) were incubated in
96-well microtiter plates in the presence or absence of 5nM TPA for up to 72 h. The cells were radiolabelled with about 0.5 μCi/well [3 H]
thymidine for 15 h and at the time points indicated, the cells were harvested and the radioactivity was quantified in a β-scintillation counter. The
incorporated [3 H] thymidine was calculated as percentage of the appropriately untreated control cells at each time point which were set to
100%. Data represent the mean± s.d. (n = 10).
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activity as compared to pMTH1-U937, however, this tel-
omerase activity increased 24 h and 48 h after exposure
to the tumor promoter TPA and prevailed at lower levels
after a 72 h TPA incubation (Figure 1a). These findings
indicated a sustained tumorigenic potential of asCD11b-
U937 cells in the presence of the phorbol ester whereby
TPA may also affect further known signalling pathways
such as PKC activation [11].
The proliferation of wild-type U937 and pMTH1-
U937 cells as measured by [3H]thymidine incorporation
revealed a significant reduction by about 75% to 85%
after 72 h of TPA treatment (Figure 1b) which is in
agreement with previous studies demonstrating TPA-
mediated growth inhibition [1,10,11]. In contrast, phor-
bol ester exposure to asCD11b-U937 cells was associated
with a sustained [3 H]thymidine incorporation in more
than 80% of the cells (Figure 1b).
In order to examine the consequences of CD11b
down-modulation on some surface molecules during
phorbol ester treatment, FACS analysis was performed
to evaluate the integrin levels and expression of distinct
monocytic markers in the pMTH1-U937 control vector
and asCD11b populations (Figure 2). There was little if
any detectable constitutive expression of CD11b in
either wild-type U937, pMTH1-U937 or asCD11b-U937
cells (Figure 2a). However, phorbol ester treatment
revealed an induction of CD11b antigen expression to
70.7% and 71.7% after 72 h of in U937 wild-type and
pMTH1-U937 cells, respectively, whereas asCD11b-
U937 demonstrated only an induction of 18.0% (n = 3)
(Figure 2a). Other members of the β2-integrin family, in-
cluding CD11a, CD11c and the β-subunit CD18 were
expressed in an enhanced fashion after TPA treatment
of pMTH1-U937 which is in concert with previous find-
ings in TPA-treated U937 cells [5]. These levels were
even further elevated in TPA-stimulated pMTH1-U937
cells cultured on 2% agarose which non-specifically
blocks cell-to-substrate adherence (Figure 2b). Similar
findings were observed for CD11a, CD11c, and CD18 in
asCD11b-U937, although the induction levels of CD11a
were more pronounced than in pMTH1-U937, whereas
less induction was observed for CD11c and CD18 when
compared to pMTH1-U937 (Figure 2b).
Previous work has demonstrated that phorbol ester
treatment of U937 cells is also associated with enhanced
expression of monocytic differentiation markers includ-
ing CD14 [6]. Similar results were obtained in pMTH1-
U937 cells. Incubation of these cells with TPA in the
absence or presence of an agarose layer demonstrated a
significant induction of monocytic epitopes recognized
by anti-CD14 and anti-F4-80 antibodies, respectively
(Figure 2b). In contrast, there was little if any induction
of the monocytic surface markers detectable in TPA-treated asCD11b-U937 cells on either plastic or agarose
(Figure 2b). Together, these data demonstrated a reduced
induction of both, CD11b and certain monocytic differenti-
ation markers in antisense CD11b transfectants following
TPA stimulation suggesting differentiation defects and
functional alterations due to the down-modulation of the
CD11b integrin. This hypothesis is supported by the meas-
urement of the macrophage inflammatory protein-1-alpha
(Mip-1α) release as a functional marker of activated mono-
cytic/macrophages (Table 1). Whereas wild-type U937 and
pMTH1-U937 cells progressively increased the Mip-1α
production to about 372 ng/ml and 344 ng/ml within 72 h
of TPA treatment, respectively, the amount of Mip-1α
remained below detection limit in asCD11b-U937 cells and
reached about 1 ng/ml only after 72 h (Table 1).
In order to further test the hypothesis of differenti-
ation defects and functional alterations due to the down-
modulation of the CD11b integrin, Western blots were
applied to analyze expression levels of intra- and extra-
cellular protease systems as potential metabolic factors.
Whereas phorbol ester treatment and a maturation
along the monocyte/macrophage lineage is associated
with enhanced metabolic activities in distinct subcellular
compartments, expression of mitochondria-associated
manganese superoxide dismutase (MnSOD) which cata-
lyzes the dismutation of superoxide into oxygen and
hydrogen peroxide, revealed enhanced protein levels in
pMTH1-U937 cells as compared to asCD11b-U937 cells
(Figure 3a). Similarly, expression of the AAA ATPase
valosin-containing protein (VCP/p97) which contributes
to protein degradation and cell cycle regulation was ele-
vated in pMTH1-U937 cells following TPA exposure
(Figure 3a). Alpha-subunits of the 20 S proteasome
detected by the appropriate antibody demonstrated a
nearly unaltered expression in the different cultures of
pMTH1-U937 and asCD11b-U937 cells, respectively
(Figure 3a). Extracellular matrix proteinases were also
tested since previous work has implicated an involve-
ment of these factors in the cell attachment of human
myeloid leukemia cells during the course of phorbol
ester-induced monocytic differentiation [14]. Thus, the
matrix metalloproteinases MMP-1, MMP-7 and MMP-9
were expressed in an enhanced fashion in TPA-treated
pMTH1-U937 in contrast to asCD11b-U937 cells with
little if any detectable MMP induction (Figure 3b).
While previous work has demonstrated that unaltered
amounts of 20 S proteasome proteins may still represent
different activity levels due to altered proteasomal regu-
lations [16], the metabolic activities were measured for
the 20 S proteasome (Figure 4). Indeed, the steady-state
level (control) of pMTH1-U937 exhibited a nearly 2-fold
enhanced proteasomal activity as compared to the
asCD11b-U937 cells (Figure 4). Following TPA treatment,
pMTH1-U937 cells revealed a progressively reduced 20 S
Figure 2 (See legend on next page.)
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Figure 2 Flow cytometry analysis of cell surface markers. a) Wildtype U937 cells, pMTH1-U937 and asCD11b-U937 were compared with respect
to the expression of the CD11b antigen in both, steady-state culture and following a 72 h exposure to 5nM TPA. An IgG1 subclass staining serves as a
control which was not altered in the different populations. b) Untreated pMTH1-U937 (pMTH1) and untreated asCD11b-U937 (asCD11b) cells were
cultured in either uncoated or 2% (w/v) agarose-precoated cell culture dishes. Following 72 h of incubation with 5nM TPA, respectively, the cells were
harvested and flow cytometry analysis was performed in the different populations with the β2-integrin subunit antibodies CD11a, CD11c and CD18 as
well as with the monocytic differentiation markers CD14 and F4-80. The relative fluorescence intensity represents the fold induction which has been
normalized separately for the appropriate control cell population. Data represent the mean± s.d. of three measurements.
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asCD11b-U937 cells which demonstrated a significant in-
crease in the proteasomal proteolytic activity (Figure 4).
While the results of pMTH1-U937 cells are in agreement
with those of TPA-induced wild-type U937 cells [13],
these findings suggested that down-modulation of the
CD11b integrin significantly altered the proliferative and
differentiation capacity of the cells associated with marked
intra- and extracellular metabolic changes.
Metabolic activities were also tested for the gelatinase
activity of MMPs by performing a zymographic assay
(Figure 5). Whereas U937 controls, pMTH1-U937 and
asCD11b-U937 did not exhibit significant gelatinase
activity as compared to the medium control, a 72 h
TPA-treatment was associated with a significantly detect-
able gelatinase activity in U937 and pMTH1 cells which
corresponded to the approximately 92 kDa MMP-9 and
further proteases of about 43 kDa and 45 kDa according
to the molecular weight standard on both sides of the gel
(Figure 5). In contrast, gelatinase activities in asCD11b-
U937 cells remained at undetectable levels after phorbol
ester exposure (Figure 5). These activity levels are in
agreement with the TPA-induced MMP data in Figure 3b
by correlating significantly enhanced gelatinase activity
with the elevated MMP expression levels in TPA-treated
pMTH1-U937 in contrast to asCD11b-U937.
Discussion
Phorbol ester treatment of non-adherent human myeloid
leukemia cells is associated with cell attachment to form
3-dimensional cell aggregates, growth arrest and monocy-
tic differentiation, and conversely, the reversible process of
retrodifferentiation and rejuvenation reveals the loss of
previously acquired monocytic features, a regained prolif-
erative capacity and cell detachment to form again a single
cell suspension of monoblastoid precursor cells [4,5].Table 1 Measurement of Mip-1α release
Production and secretion of Mip-1α [ng/ml] following stimulation with
0h 4h 8h
U937 n.d. 0.21 ± 0.16 19.75 ± 0.55
pMTH1-U937 n.d. 0.21 ± 0.16 23.53 ± 1.66
asCD11b-U937 n.d. 1.20 ± 0.11 3.06 ± 0.03
About 5x105 U937 cells, pMTH1-U937 and asCD11b-U937 cells were incubated in th
points indicated aliquots from the cell supernatants were applied to a Mip-1α ELISA
ml (n.d. = not detectable (below detection limit)). Data represent the mean ± s.d. ofWhereas these findings suggested a tight regulatory rela-
tionship between adherence, cell growth and metabolic
changes, previous work has documented a predominant
role of the β2-integrin CD11b in TPA-induced adherence
of human leukemic cells [6]. Moreover, this role was abol-
ished after down-modulation of β2-integrin CD11b in
antisense transfectants by sustained telomerase and prolif-
erative activity and failed monocytic differentiation after
TPA treatment.
A functional β2 integrin composition in monocytic cells
is involved in adhesion, transendothelial migration and
phagocytosis [17] and it can relay downstream signals for
cell polarity via the small Rho GTPase Cdc42 in neutrophils
[18], however, the detailed signalling mechanisms of the
β2-integrins via downstream kinases to contribute to a
regulatory balance between adhesion-mediated cell cycle
progression and a paralleled differentiation program remain
unclear.
Recent data suggested that during an inflammatory
response the functional CD11b/CD18 integrin complex,
which represents the complement receptor-3, mediates
phagocytosis depending on the activation of certain Rho
GTPases [19]. Moreover, an inflammation-accompanied
activation of CD11b/CD18 in murine peripheral blood
mononuclear cells relayed a downstream signalling cascade
via FAK/PI3K/Akt/NF-kappaB with subsequent expression
of pro-inflammatory cytokines [20]. Thus, enhanced cyto-
kine release such as the increased macrophage inflamma-
tory protein-1-alpha (Mip-1α) production in TPA-activated
pMTH1 transfectants and U937 cells indicated a functional
β2 integrin signalling cascade via downstream kinases and
transcription factors and conversely, these effects appear to
be abolished in asCD11b cells which were unable to pro-
duce significant amounts of Mip-1α.
The failure of asCD11b cells to respond to TPA-activated
kinases and phosphatases with the induction of a5nm TPA
24h 48h 72h
302.06 ± 22.00 331.11 ± 15.26 372.47 ± 35.47
340.45 ± 24.41 334.87 ± 7.89 344 ± 33.30
3.20 ± 0.06 2.10 ± 0.08 1.06 ± 0.15
e absence or presence of 5nM TPA for up to 72 h, respectively. At the time
. The results are expressed as ng Mip-1α/ml with a detection limit below 6 pg/
one experiment performed in triplicate.
Figure 3 Western blot analysis. The pMTH1-U937 (pMTH1) and asCD11b-U937 (asCD11b) cells were cultured in the absence and in the
presence of 5nM TPA for 24 h up to 72 h, respectively. Thereafter, the different populations were harvested, lyzed and 40 μg of total cellular
protein was separated by 10% SDS-PAGE followed by Western blotting. a) For the expression of the metabolic enzymes MnSOD, p97/VCP and
the 20 S proteasome (α-subunits), gels were subsequently stripped corresponding to a β-actin loading control. b) Analysis of the expression
patterns of different extracellular matrix proteolytic enzymes were tested using antibodies against MMP-1, MMP-7 and MMP-9 for matrix
restructuring. The unaltered expression level of β-actin serves as a loading control.
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transfectants and U937 cells may elevate the superoxide
anion production and DNA damage products [21-23] due
to the inability of macrophage-like maturation and appro-
priate metabolic responses. Indeed, these effects may
accumulate oxidative stress products in asCD11b cells and
increased protein damage since the expression of reactive
oxygen species (ROS)-metabolizing enzymes such as
MnSOD or the expression of the chaperone p97/VCP in
ubiquitin-dependent proteasomal degradation remained
at low levels in contrast to the pMTH1 transfectants,respectively. Previous work has demonstrated that CD11b
stimulation in monocytes can promote IL8 and Mip-1α
production via a proteasome-dependent NF-κB activation
which may in part explain the low steady-state proteasomal
activity levels in the asCD11b transfectants most probably
lacking a sufficient threshold of CD11b stimulation [24].
Moreover, a significantly increasing proteasomal proteo-
lytic activity was observed despite of unchanged protein
expression levels of the 20 S proteasome α-subunits.
Whereas the 20 S proteasome represents a large 700 kDa
multicatalytic and multisubunit proteinase complex, these
Figure 4 20S proteasomal proteolytic activity. The pMTH1-U937 and asCD11b-U937 cells were treated with 5nM TPA for 4 h up to 72 h. At
the time points indicated the cells were harvested and nuclear extracts were measured by a fluorometric proteolytic assay to obtain the 20 S
proteasomal activity. The relative proteasomal activity of pMTH1-U937 control cells in steady-state was set to 100%. Data represent the mean±
s.d. of three independent experiments.
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composition. Other findings have demonstrated that poly
(ADP-ribose) polymerase-1 (PARP-1) displays regulatory
effects on the 20 S proteasomal activity [14,16,25] and
similar mechanisms may contribute to the effects observed
in asCD11b-U937. Indeed, the 20 S proteasome data are
in agreement with previous work, demonstrating an un-
changed proteasome protein expression despite of a
markedly elevated proteasomal proteolytic activity in ROS-
induced U937 cells. These effects were due to an oxidative
stress-induced altered proteasomal regulation [13,16] sug-
gesting a continuous accumulation of damaging productsFigure 5 Zymographic assay of gelatinase activity. Medium supernatan
conditioned medium from 107 U937 cells, pMTH1-U937 cells and asCD11b
respectively, were 18-fold concentrated and subjected to SDS-PAGE contai
buffer, the gels were stained with 0.4% Coomassie blue and afterwards des
bands against the dark background. The molecular weight markers on both
activities.in TPA-exposed asCD11b-U937 cells which eventually
leads to massive apoptosis in a certain part of the popula-
tion as documented earlier [1,12]. An accumulation of
damage products, e.g. ROS, may also activate apoptosis-
associated proteases (e.g. caspases) for PARP-1 cleavage
[26]. In contrast, the progressive decline of proteasomal
activity in TPA-treated pMTH1 transfectants is also sub-
stantiated by previous reports during phorbol ester-induced
differentiation of U937 cells [13].
In concert with the regulation of these intracellular
proteolytic systems, extracellular matrix metallopro-
teases such as MMP-1, MMP-7 and MMP-9 have beents of 20 ml culture medium (medium control) as well as 20 ml
-U937 cells in the absence or presence of 5nM TPA for 72 h,
ning 2 mg/ml of gelatine. Following incubation with MMP enzyme
tained again to visualize the appearance of gelatinase activity by light
sides of the gels indicate the size of the MMPs exhibiting gelatinase
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autoimmune disorders to provide and actively change an
appropriate microenvironment for the tumor cells as well
as relay intracellular signals by involving cytokine receptors
such as CXCR4 [27-29]. Thus, previous work in TPA-
induced differentiating myeloid leukemic cells has demon-
strated a strong induction of these matrix metalloproteases
[14] which is in accordance with differentiating pMTH1
U937 cells and in contrast to the asCD11b transfectants.
These findings reflect a relevance for β2-integrin-mediated
signalling with the extracellular matrix substantiating the
importance of an appropriate tumor cell microenvironment
and restructure [30-32]. Moreover, these effects appear to
be specific for CD11b since alternative β2-integrins such as
CD11a/CD18 and CD11c/CD18 do not compensate these
metabolic alterations.
In summary, these findings suggested an important role
of the functional β2-integrin CD11b/CD18 to coordinate
the cell attachment and a subsequent monocytic matur-
ation program upon phorbol ester induction. Thus, a block
in CD11b/CD18-mediated adherence and regulatory imbal-
ances can result in additional secondary effects after TPA
stimulation, such as a derailed regulation of proliferation
and a failed extracellular matrix restructuring by the lack of
a sufficient production of matrix metalloproteinases. More-
over, reduced availability of distinct intracellular protease
systems may reflect an insufficient adaptation to monocytic
metabolism following induction of differentiation.
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